Skip to main content
Investors
Scibase.com
Open menu
At a Glance
Open link menu
At a Glance
Investment Case
Our Strategy
Market Overview
Results & Reports
Open link menu
Results & Reports
Calendar
Financial Data
The Share
Open link menu
The Share
Shareholders
Insider Transactions
Analysts
Prospectus Regarding Shares
Share Capital Development
Warrants
Governance
Open link menu
Governance
Management and Board of Directors
Annual General Meeting
Articles of Association
Auditor
Certified Advisor
Committees
ESG - sustainability
Releases
Open link menu
Releases
Subscription Service
EN
Current language English, click to switch language
SV
Switch to Svenska
Search
Search
Search
Search on a site
Please fill out this field
Back
Close menu
Search on a site
Please fill out this field
Close
Interim report
Nov 07 2025
Interim report
Nov 07 2025
The Board of Directors in SciBase resolves on an offer to repurchase outstanding warrants of series TO 2 and intends to resolve on a rights issue of shares of approximately SEK 83 million
Nov 07 2025
SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million
Oct 22 2025
Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2026
Sep 26 2025
Nevisense Used in Fundamental Skin Barrier Research on Atopic Dermatitis
Sep 23 2025
SciBase receives initial order for clinical study from Castle Biosciences
Sep 10 2025
Main owners strengthen their position in SciBase
Aug 28 2025
New Clinical Publication in Karger Dermatology Confirms Reader Studies as Key to Validating Nevisense
Interim report
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Last page
Subscribe to
Close popup
Left
Right
